title: Altered expression of neuropeptides in the primary somatosensory cortex of the Down syndrome model Ts65Dn.
abstract: Down syndrome is the most common genetic disorder associated with mental retardation. Subjects and mice models for Down syndrome (such as Ts65Dn) show defects in the formation of neuronal networks in both the hippocampus and the cerebral cortex. The principal neurons display alterations in the morphology, density and distribution of dendritic spines in the cortex as well as in the hippocampus. Several evidences point to the possibility that the atrophy observed in principal neurons could be mediated by changes in their inhibitory inputs and, in fact, an imbalance between excitation and inhibition has been observed in Ts65Dn mice in these regions, which are crucial for learning and information processing. These animals have an increased density of interneurons in the primary somatosensory cortex, especially of those expressing calretinin and calbindin D-28k. Here, we have analysed the expression and distribution of several neuropeptides in the primary somatosensory cortex of Ts65Dn mice in order to investigate whether these subpopulations of interneurons are affected. We have observed an increase in the total density of somatostatin expressing interneurons and of those expressing VIP in layer IV in Ts65Dn mice. The typology of the somatostatin and VIP interneurons was unaltered as attested by the pattern of co-expression with other markers. Somatostatin immunoreactive neurons co-express mainly D-28k calbindin and VIP expressing interneurons maintain its pattern of co-expression with calcium binding proteins. These alterations, in case they were also present in subjects with Down syndrome, could be related to their impairment in cognitive profile and could be involved in the neurological defects observed in this disorder.
authors.affiliation: Neurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de València, Spain.
authors.forename: Samuel
authors.initials: S
authors.lastname: Hernández
authors.forename: Javier
authors.initials: J
authors.lastname: Gilabert-Juan
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Blasco-Ibáñez
authors.forename: Carlos
authors.initials: C
authors.lastname: Crespo
authors.forename: Juan
authors.initials: J
authors.lastname: Nácher
authors.forename: Emilio
authors.initials: E
authors.lastname: Varea
mesh_terms: D000818:Animals; D002135:Calcium-Binding Proteins / Q000378:metabolism; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000378:metabolism* / Q000473:pathology; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D007395:Interneurons / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D009474:Neurons / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism*; D013003:Somatosensory Cortex / Q000378:metabolism* / Q000473:pathology; D013004:Somatostatin / Q000378:metabolism
chemical_list: D002135:Calcium-Binding Proteins; D009479:Neuropeptides; D013004:Somatostatin